ADO

0.00%

2.1¢ anteotech ltd

Riverbrae - Snookered, page-16

First 16 Last

Share
Profile

Follow
slippin

8,206 Posts.

1138

23/05/17

19:24

Post #: 24867273
Share

Originally posted by bourbasted ↑

A deal with Ellume has been done. In answer to your question, no, they aren't responsible for supplying and manufacturing the whole test insert/cartridge unless something has changed from the original ann back in Oct '16:

"Anteo Diagnostics Limited (ASX: ADO) is pleased to announce that it has entered a long term supply arrangement with Ellume Pty Ltd. based in Brisbane, Australia. (This = a deal)

Established in 2010, Ellume has developed a pioneering quantum dot detection system combining nano-technology and unique opto-electronics resulting in a next generation immunoassay platform. Ellume has used this technology to create products distinguished by their technical performance, simplicity of design, ease of use, rapid time to result and connectivity.

Anteo worked with Ellume in the early stages of quantum dot enablement to deliver a customised formulation of Anteo’s unique metal-ion based nanometre-thin chemistry.

Anteo COO Ms Tamara Mills said, “We are pleased to see that Anteo’s technology has delivered a strong technical proposition and commercial solution for Ellume. We believe Anteo’s platform technology is well placed to enable the next wave of breakthrough PoC technologies, particularly as the limitations of the traditional biomolecule coupling methods struggle to meet the demands associated with nano-technology.”

Ellume Managing Director, Dr Sean Parsons, said, “Anteo technology forms an important layer in our proprietary quantum-dot based technology and we are pleased to have entered into this long-term agreement.”

The undisclosed commercial arrangement (a deal, but not sure if it's a good one or not) shall see Ellume utilise Anteo’s proprietary technology across its suite of pipeline products. The first to be launched influenza product will be released to the professional market in 2017. Other pipeline products include Respiratory Syncytial Virus, Group A Streptococcus and Chlamydia."

All IMHO, FWIW, DYOR, TJAB, blah blah blah....

Expand

"We believe Anteo’s platform technology is well placed to enable the next wave of breakthrough PoC technologies, particularly as the limitations of the traditional biomolecule coupling methods struggle to meet the demands associated with nano-technology.”

The next wave of breakthrough PoC technologies.

It does sound hopeful. doesn't it?

ADO Price at posting: 2.8¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 70 more messages in this thread...

First 16 Last

Add ADO (ASX) to my watchlist

(20min delay)
Last 2.1¢		Change 0.000(0.00%)		Mkt cap ! $52.28M

Open	High	Low	Value	Volume
2.1¢	2.2¢	2.0¢	$12.51K	612.0K

Buyers (Bids)

No.	Vol.	Price($)
9	1790998	2.0¢

Sellers (Offers)

Price($)	Vol.	No.
2.1¢	32423	1

View Market Depth

No.	Vol.	Price($)
9	1790998	0.020
8	1727381	0.019
4	468115	0.018
2	64748	0.017
1	420000	0.016

Price($)	Vol.	No.
0.022	700616	2
0.023	322844	5
0.024	741966	3
0.025	1118820	11
0.026	291415	3

Last trade - 16.10pm 27/09/2024 (20 minute delay)

ADO (ASX) Chart

Riverbrae - Snookered, page-16

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ACCC seeks Olam divestments before it can buy Namoi Cotton

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Riverbrae - Snookered, page-16

Top Stories

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ACCC seeks Olam divestments before it can buy Namoi Cotton

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News